Who should treat patients with peripheral arterial disease - The vascular specialist

European Journal of Vascular and Endovascular Surgery

Volumn 24, Issue 1, 2002, Pages 1-5

  Sillesen, H ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ANGIOCARDIOGRAPHY; ARTERY DISEASE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; DISEASE SEVERITY; EDITORIAL; HEART PROTECTION; ISCHEMIC HEART DISEASE; LEG ISCHEMIA; MEDICAL SPECIALIST; MORTALITY; PRIORITY JOURNAL; RISK REDUCTION; SMOKING CESSATION; SURVIVAL; VASCULAR SURGERY; WALKING; CORONARY ARTERY DISEASE; HEALTH BEHAVIOR; HUMAN; PATIENT CARE; PERIPHERAL VASCULAR DISEASE; PUBLIC RELATIONS; RISK ASSESSMENT; STANDARD; SURGERY;

CORONARY DISEASE; HEALTH BEHAVIOR; HUMANS; INTERPROFESSIONAL RELATIONS; PATIENT CARE; PERIPHERAL VASCULAR DISEASES; RISK ASSESSMENT; SPECIALTIES, SURGICAL;

EID: 0036631479     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1671     Document Type: Editorial

References (20)

1. DORMANDY J, HEECK L, VIG S. The natural history of claudication: risk to life and limb. Semin Vasc Surg 1999; 12: 123-137.
2. CRIQUI MH, LANGER RD, FRONEK A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 328: 381-386.
3. BISMUTH J, KLITFOD L, SILLESEN H. The lack of management of concomittant coronary disease in patients with peripheral atherosclerotic disease. Eur J Vasc Endovasc Surg 2001; 21: 143-146.
4. MULUK SC, MULUK VS, KELLEY ME et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg 2001; 33: 251.
5. HERTZER NR, BEVEN EG, YOUNG JR, O'HARA PJ et al. Coronary artery disease in peripheral vascular patients. Ann Surg 1984; 199: 223-233.
6. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 2000; 19: S144-S243.
7. LENG GC, FOWLER B, ERNST E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000; 2: cd000990.
8. HIATT WR. Medical treatment of perpheral arterial disease and claudication. New Engl J Med 2001; 344: 1608-1621.
9. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
10. SHEPHERD J, COBBE SM, FORD I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307.
11. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-1357.
12. RIDKER PM, RIFAI N, PFEFFER MA et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998; 98: 839-844.
13. DOWNS JR, CLEARFIELD M, WEIS S et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-1622.
14. Heart Protection Study. Presented at American Heart Association in Los Angeles, Nov. 11-14, 2001.
15. Antiplatelet Triallists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
16. THE HEART OUTCOME PREVENTION EVALUATION STUDY INVESTIGATORS. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000; 342: 145-153.
17. OSTERGREN JB, POGUE J, SLEIGHT P, DAGENAIS K, YUSUF S. Ankle-Brachial blood pressure index is a strong predictor of mortality and cardiovascular events. Results from the HOPE trial. J Am Coll Cardiology. 2001, 37: A1-A648.
18. EXECUTIVE SUMMARY OF THE THIRD REPORT OF THE NATIONAL CHOLESTEROL EDUCATIONAL PROGRAM (NCEP). Expert Panel on detection, evaluation and treatment og high bloof cholesterol in adults. JAMA 2001; 285: 2486-2497.
19. NASS CM, ALLEN JK, JERMYN RM, FLEISCHER LA. Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral artery disease. Vascular Medicine 2001; 6: 35-41.
20. HIRSCH AT, CRIQUI MH, TREAT-JACOBSEN D et al. Peripheral arterial disease detection, awareness and treatment in primary care. JAMA 2001; 286: 1317-1324.